TY - JOUR
T1 - Mohs micrographic surgery for the treatment of hidradenocarcinoma
T2 - The mayo clinic experience from 1993 to 2013
AU - Tolkachjov, Stanislav N.
AU - Hocker, Thomas L.
AU - Hochwalt, Phillip C.
AU - Camilleri, Michael J.
AU - Arpey, Christopher J.
AU - Brewer, Jerry D.
AU - Otley, Clark C.
AU - Roenigk, Randall K.
AU - Baum, Christian L.
N1 - Publisher Copyright:
© 2015 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
PY - 2015/2/13
Y1 - 2015/2/13
N2 - BACKGROUND: Hidradenocarcinoma (HAC) is a rare malignant adnexal neoplasm with reported metastatic potential and undefined optimal treatment. OBJECTIVE: To review clinical characteristics and outcomes of patients with HAC treated with Mohs micrographic surgery (MMS). MATERIALS AND METHODS: The authors performed a retrospective chart review of patients with HAC treated by MMS at Mayo Clinic from 1993 to 2013, recording patient demographics, tumor characteristics, MMS stages to clearance, follow-up, recurrence, metastasis, and mortality. RESULTS: Ten patients underwent MMS for HAC more than 20 years. The average age was 62.8 years, with 6 females and 4 males. Occipital scalp was the most common location (40%), followed by extremities (30%) and face (20%). In 5 of 7 cases (71%), "cyst" was the working clinical diagnosis. The average preoperative lesion area was 3.18 cm, with an average of 1.5 MMS stages required for clearance. Mean postoperative follow-up was 7 years (range, 5-205 months). No tumors treated with MMS recurred, metastasized, or led to disease-related mortality. CONCLUSION: Mohs micrographic surgery seems to be a useful treatment modality for HAC. This is the largest reported series of HAC treated with MMS with long-term follow-up.
AB - BACKGROUND: Hidradenocarcinoma (HAC) is a rare malignant adnexal neoplasm with reported metastatic potential and undefined optimal treatment. OBJECTIVE: To review clinical characteristics and outcomes of patients with HAC treated with Mohs micrographic surgery (MMS). MATERIALS AND METHODS: The authors performed a retrospective chart review of patients with HAC treated by MMS at Mayo Clinic from 1993 to 2013, recording patient demographics, tumor characteristics, MMS stages to clearance, follow-up, recurrence, metastasis, and mortality. RESULTS: Ten patients underwent MMS for HAC more than 20 years. The average age was 62.8 years, with 6 females and 4 males. Occipital scalp was the most common location (40%), followed by extremities (30%) and face (20%). In 5 of 7 cases (71%), "cyst" was the working clinical diagnosis. The average preoperative lesion area was 3.18 cm, with an average of 1.5 MMS stages required for clearance. Mean postoperative follow-up was 7 years (range, 5-205 months). No tumors treated with MMS recurred, metastasized, or led to disease-related mortality. CONCLUSION: Mohs micrographic surgery seems to be a useful treatment modality for HAC. This is the largest reported series of HAC treated with MMS with long-term follow-up.
UR - http://www.scopus.com/inward/record.url?scp=84922683861&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922683861&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000000242
DO - 10.1097/DSS.0000000000000242
M3 - Article
C2 - 25627632
AN - SCOPUS:84922683861
SN - 1076-0512
VL - 41
SP - 226
EP - 231
JO - Dermatologic Surgery
JF - Dermatologic Surgery
IS - 2
ER -